THR beta agonist
Showing 1 - 25 of 5,330
Healthy Trial in Edmonton (Salbutamol 400mcg, Budesonide/formoterol, Placebo)
Recruiting
- Healthy
- Salbutamol 400mcg
- +2 more
-
Edmonton, Alberta, CanadaClinical Physiology Laboratory
Sep 5, 2023
Moderate Asthma Trial (Long-Acting Beta Agonist)
Not yet recruiting
- Moderate Asthma
- Long-Acting Beta Agonist
- (no location specified)
Feb 24, 2023
Urgency Urinary Incontinence Trial in United States (Beta3-Agonists, Adrenergic, OnabotulinumtoxinA 100 UNT [Botox])
Not yet recruiting
- Urgency Urinary Incontinence
- Beta3-Agonists, Adrenergic
- OnabotulinumtoxinA 100 UNT [Botox]
-
Birmingham, Alabama
- +4 more
Mar 28, 2023
Overactive Bladder Syndrome Trial run by the (Vaginal estrogen, Mirabegron 50 MG [Myrbetriq])
Recruiting
- Overactive Bladder Syndrome
- Vaginal estrogen
- Mirabegron 50 MG [Myrbetriq]
-
Bethesda, MarylandWalter Reed National Military Medical Center
Nov 3, 2022
Moderate to Severe Asthma Exacerbation Trial in Poitiers (Standard Nebulization, A - Vibrating mesh nebulization, B - Vibrating
Not yet recruiting
- Moderate to Severe Asthma Exacerbation
- Standard Nebulization
- +2 more
-
Poitiers, FranceUniversity Hospital of Poitiers
Jan 11, 2023
Thermogenesis Trial in Basel (Fenoterol, Mild cold exposure)
Recruiting
- Thermogenesis
- Fenoterol
- Mild cold exposure
-
Basel, SwitzerlandUniversity Hospital Basel, Dept. of Endocrinology
Apr 27, 2022
Type 2 Diabetes, Obesity Trial in Sherbrooke (drug, other, diagnostic test, procedure)
Recruiting
- Type 2 Diabetes
- Obesity
- Formoterol Fumarate 12 micrograms Inhalation Powder
- +8 more
-
Sherbrooke, Quebec, CanadaCentre de recherche du CHUS
Sep 22, 2022
Transient Tachypnea of the Newborn Trial (Epinephrine Inhalation Solution, Salbutamol, Saline Inhalants)
Completed
- Transient Tachypnea of the Newborn
- Epinephrine Inhalation Solution
- +2 more
- (no location specified)
Aug 7, 2021
Sjogren's Syndrome, Overactive Bladder Syndrome Trial in Taichung (mirabegron, oxybutynin, tolterodine, solifenacin)
Recruiting
- Sjogren's Syndrome
- Overactive Bladder Syndrome
- mirabegron
- oxybutynin, tolterodine, solifenacin
-
Taichung, TaiwanChina Medical University Hospital
Aug 8, 2021
Patients With Low Bladder Compliance of 20ml/H2O or Less Despite Taking Anticholinergics Trial in Seoul (Mirabegron
Active, not recruiting
- Patients With Low Bladder Compliance of 20ml/H2O or Less Despite Taking Anticholinergics
- Mirabegron (beta3-adrenoceptor agonist), Anticholinergics
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Feb 15, 2023
Reversibility of Bronchial Obstruction in Children Born Preterm
Recruiting
- Bronchopulmonary Dysplasia
- +6 more
-
Prague, CzechiaFirst faculty of Medicine, Charles university.
Oct 29, 2023
Spinal Cord Injury, Respiratory Muscle Weakness Trial in Bronx (Oral Albuterol Extended Release, Placebo)
Active, not recruiting
- Spinal Cord Injury
- Respiratory Muscle Weakness
- Oral Albuterol Extended Release
- Placebo
-
Bronx, New YorkJames J. Peters VA Medical Center, Bronx, NY
Nov 8, 2022
COPD Trial in Llanelli (Any LABA/LAMA)
Completed
- Chronic Obstructive Pulmonary Disease
- Any LABA/LAMA
-
Llanelli, Carmarthenshire, United KingdomPrince Philip Hospital
Aug 2, 2022
Pulmonary Disease, Chronic Obstructive Trial in New Zealand, Thailand, United Kingdom (400 microgrammes GSK961081, 1200
Completed
- Pulmonary Disease, Chronic Obstructive
- 400 microgrammes GSK961081
- 1200 microgrammes GSK961081
-
Wellington, New Zealand
- +3 more
Sep 28, 2021
Metastatic Pancreatic Adenocarcinoma Trial (odetiglucan, CDX-1140)
Not yet recruiting
- Metastatic Pancreatic Adenocarcinoma
- odetiglucan
- CDX-1140
- (no location specified)
Jul 29, 2022
Asthma, Nonadherence, Medication Trial in Saint Louis (Adherence to symptom driven budesonide/formoterol as compared to
Recruiting
- Asthma
- Nonadherence, Medication
- Adherence to symptom driven budesonide/formoterol as compared to adherence to maintenance ICS and symptom-driven SABA
-
Saint Louis, MissouriWashington University in St. Louis School of Medicine
Jan 8, 2023
Bronchial Asthma Trial in Chandigarh (Single Inhalation technique, Tidal inhalation technique)
Recruiting
- Bronchial Asthma
- Single Inhalation technique
- Tidal inhalation technique
-
Chandigarh, India
- +1 more
Jun 23, 2022
Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) Trial in Melbourne, Sydney, Copenhagen Ø (Mirabegron, Placebo)
Completed
- Chronic Heart Failure With Reduced Ejection Fraction (HFrEF)
- Mirabegron
- Placebo
-
Melbourne, Australia
- +2 more
Oct 14, 2020
Overactive Bladder Syndrome, Detrusor Overactivity Trial (Mirabegron 50 MG, Solifenacin Succinate 5 MG)
Not yet recruiting
- Overactive Bladder Syndrome
- Detrusor Overactivity
- Mirabegron 50 MG
- Solifenacin Succinate 5 MG
- (no location specified)
Jan 25, 2021
Overactive Bladder Syndrome Trial in Banqiao (Mirabegron, Solifenacin)
Recruiting
- Overactive Bladder Syndrome
-
Banqiao, New Taipei, TaiwanDepartment of Obstetrics and Gynecology, Far-Eastern Memorial Ho
Feb 7, 2022
Asthma in Children Trial (Bi-level Positive Airway Pressure, Sham Bi-level Positive Airway Pressure)
Not yet recruiting
- Asthma in Children
- Bi-level Positive Airway Pressure
- Sham Bi-level Positive Airway Pressure
- (no location specified)
Apr 27, 2023